S.-G. Chen et al. / Tetrahedron 66 (2010) 4057–4062
4061
125.4, 121.4, 120.9, 119.4, 113.9, 110.1, 107.5, 46.66, 35.77, 35.08,
34.93, 31.80, 31.65, 16.96. MS (MALDI-TOF): m/z 1220.0 [MþH]þ.
HRMS (MALDI-FT): calcd for C81H91N10O 1219.7372 [M]þ. Found:
1219.7374.
d 170.1, 150.9, 147.3, 134.5, 132.0, 123.7, 57.06, 44.57, 30.31, 19.41. MS
(ESI): m/z 381 [MþH]þ. Anal. Calcd for C22H28N4O2: C, 69.45; H, 7.42;
N, 14.73. Found: C, 69.02; H, 7.70; N, 14.64.
4.1.8. Compound S,S 3. Compound S,S 3 was prepared by using the
4.1.4. Compound 1. Compound 8 (30 mg, 0.027 mmol) was dis-
solved in the solution of zinc acetate in dichloromethane and
methanol (4:1) (0.05 M, 5 mL) and stirred at room temperature for
12 h. After removing the solvents with a rotavapor, the resulting
residue was dissolved in dichloromethane (20 mL). The solution
was washed with water (10 mL) and brine (20 mL), and dried over
sodium sulfate. Upon removal of the solvent under reduced
pressure, compound 1 was obtained as a purple solid (33 mg,
same procedure and characterized by the 1H NMR and MS methods.
25
[a
]
ꢁ183 (c 0.54, CH2Cl2).
D
4.2. Typical procedures for the UV–vis titration and method
for determining the apparent association constants12,24
Aliquots of a fixed solution of 2, 3, and 14 in toluene were
added to a toluene solution of 1, and the mixture was subjected to
UV–vis spectroscopy at 25 ꢃC. The spectrum was corrected with
a dilution factor and background subtraction. The difference in
100%). 1H NMR (300 MHz, CDCl3):
d 14.35 (s, 1H), 11.23 (s, 1H),
10.85 (s, 1H), 8.93–8.92 (m, 8H), 8.64 (s, 1H), 8.24 (d, J¼7.0 Hz, 2H),
7.98–7.97 (m, 6H), 7.89 (d, J¼7.0 Hz, 2H), 7.74 (d, J¼7.3 Hz, 1H),
7.58–7.57 (m, 3H), 6.87 (d, J¼7.3 Hz, 1H), 5.36 (s, 1H), 5.12 (s, 1H),
4.42–4.40 (m, 2H), 1.68–1.64 (m, 3H), 1.27 (s, 54H). 13C NMR
absorbance (DA) of the receptor in the presence of the guest and
absence of the guest was recorded and the data were plotted
against [guest]. The UV–vis spectral change of the receptor upon
titration with the guest clearly showed isobestic points, suggest-
ing that each zinc porphyrin moiety in the receptor binds with
a nitrogen ligand unit. The apparent association constants were
derived by using the non-linear curve fitting based on the
equation:
(100 MHz, CDCl3)
d 165.9, 163.2, 160.4, 154.5, 150.4, 150.1, 148.4,
142.0, 141.8, 139.5, 138.1, 134.9, 132.3, 132.1, 131.7, 129.6, 125.1,
122.4, 120.7, 120.4, 113.8, 110.1, 107.6, 46.59, 37.41, 35.03, 34.88,
31.96, 31.76, 16.90. MS (MALDI-FT): m/z 1281.7 [MþH]þ. HRMS
(MALDI-FT): calcd for C81H89N10OZn 1281.6507 [M]þ. Found:
1281.6529.
ꢀ
ꢁ
À
Á
À
D
A ¼
D
AN 1 þ Kassoc½Gꢄ þ Kassoc½Hꢄ0
ꢁ
1 þ Kassoc½Gꢄ
4.1.5. Compound R,R 2. Isonicotinic acid (0.22 mg, 1.8 mmol) was
suspended in thionyl chloride (4.0 mL) and DMF (0.1 mL), heated
under reflux for 1 h and then concentrated in vacuo. The
resulting residue 12 was dissolved in pyridine (2.0 mL) and then
the solution was added to a solution of 1123 (0.1 g, 0.59 mmol) in
pyridine (2.0 mL). The mixture was stirred at 50 ꢃC for 4 h and
then concentrated under reduced pressure. The crude product
was dissolved in dichloromethane (10 mL) and the solution
washed with saturated sodium bicarbonate solution (5 mL),
water (5 mL) and brine (5 mL), and dried over sodium sulfate.
After removing the solvent, the resulting residue was purified by
ꢃꢄ
ꢂ
0:5
Á
À
Á
2
þ Kassoc½Hꢄ0 ꢁ4Ka2ssoc½Hꢄ0½Gꢄ
2Kassoc½Hꢄ0
where
D
A ¼ A ꢁ
D
A0;
D
AN ꢁ A0
[G] is the pyridine concentration of ligands (2ꢀ[2], 2ꢀ[3]
or 2ꢀ[14]).
½Hꢄ ¼ ½1ꢄ
Acknowledgements
column chromatography (CH2Cl2/CH3OH 50:1) to give com-
We thank NSFC (No. 20732007), Ministry of Science and Tech-
nology of China (2007CB-808001), Chinese Academy of Sciences
(KJCX2-YW-H13) and Science and Technology Commission of
Shanghai Municipality (09XD1405300) for financial support.
25
pound R,R 2 as a white solid (0.13 g, 57%). [
CH2Cl2). 1H NMR (300 MHz, CDCl3):
4.38 (s, 2H), 3.59 (s, 2H), 3.13–3.10 (m, 2H), 1.94–1.91 (m, 2H),
0.92–0.87 (m, 12H). 13C NMR (100 MHz, CDCl3):
170.1, 150.3,
a
]
þ148 (c 0.25,
D
d
8.70 (s, 4H), 7.34 (s, 4H),
d
143.7, 120.6, 56.84, 44.31, 30.10, 19.30. MS (ESI): m/z 381
[MþH]þ. HRMS (ESI): calcd for C22H29N4O2 [MþH]þ: 380.2291.
Found: 381.2285.
Supplementary data
Supplementary data associated with this article can be found in
4.1.6. Compound S,S 2. Compound S,S 2 was prepared by using the
same procedure and characterized by the 1H NMR and MS methods.
25
[
a]
ꢁ149 (c 0.24, CH2Cl2).
D
References and notes
4.1.7. Compound R,R 3. Isonicotinic acid (0.22 g, 1.8 mmol) was
suspended in thionyl chloride (4.0 mL) and DMF (0.1 mL). The
mixture was heated to reflux for 1 h to give a light yellow solution,
which was concentrated under reduced pressure to give compound
13, which was then dissolved in pyridine (2.0 mL). To this solution
was added dropwise a solution of compound 11 (96 mg, 0.59 mmol)
in pyridine (2.0 mL). The mixture was stirred at 50 ꢃC for 4 h and
then concentrated in vacuo. The resulting residue was dissolved in
dichloromethane (10 mL). The solution was washed with saturated
sodium bicarbonate solution (5 mL), water (5 mL) and brine (5 mL),
and dried over sodium sulfate. After removing the solvent with
a rotavapor, the resulting residue was purified by column chroma-
1. MacGillivray, L. R.; Atwood, J. L. Angew. Chem., Int. Ed. 1999, 38, 1018–1033.
2. Zimmerman, S. C.; Corbin, P. S. Struct. Bond. 2000, 96, 63–94.
3. Davis, J. T.; Spada, G. P. Chem. Soc. Rev. 2007, 36, 296–313.
4. Sessler, J. L.; Lawrence, C. M.; Jayawickramarajah, J. Chem. Soc. Rev. 2007, 36,
314–325.
5. Rebek, J., Jr. Acc. Chem. Res. 2009, 42, 1660–1668.
6. Vazquez-Campos, S.; Crego-Calama, M.; Reinhoudt, D. N. Supramol. Chem. 2007,
19, 95–106.
7. Palmans, A. R. A.; Meijer, E. W. Angew. Chem., Int. Ed. 2007, 46, 8948–8968.
8. Hembury, G. A.; Borovkov, V. V.; Inoue, Y. Chem. Rev. 2008, 108, 1–73.
9. Kumaki, J.; Sakuraiy, S.-i.; Yashima, E. Chem. Soc. Rev. 2009, 38, 737–746.
10. Prins, L. J.; De Jong, F.; Timmerman, P.; Reinhoudt, D. N. Nature 2000, 408,
181–184.
11. Feiters, M. C.; Nolte, R. J. M. Adv. Supramol. Chem. 2000, 6, 41–156.
12. Hou, J.-L.; Yi, H.-P.; Shao, X.-B.; Li, C.; Wu, Z.-Q.; Jiang, X.-K.; Wu, L.-Z.; Tung,
C.-H.; Li, Z.-T. Angew. Chem., Int. Ed. 2006, 45, 796–800.
13. Yi, H.-P.; Li, C.; Hou, J.-L.; Jiang, X.-K.; Li, Z.-T. Tetrahedron 2005, 61, 7974–7980.
14. Yi, H.-P.; Wu, J.; Ding, K.-L.; Jiang, X.-K.; Li, Z.-T. J. Org. Chem. 2007, 72, 870–877.
15. Yan, Y.; Qin, B.; Shu, Y.; Chen, X.; Yip, Y. K.; Zhang, D.; Su, H.; Zeng, H. Org. Lett.
2009, 11, 1201–1204.
16. Marsh, A.; Silvestri, M.; Lehn, J.-M. Chem. Commun. 1996, 1527–1528.
17. Kolotuchin, S. V.; Zimmerman, S. C. J. Am. Chem. Soc. 1998, 120, 9092–9093.
tography (CH2Cl2/MeOH 50:1) to give compound R,R 3 as a white
25
solid (0.14 g, 63%). [
a
]
þ187 (c 0.54, CH2Cl2). 1H NMR (300 MHz,
D
CDCl3):
d
8.72–8.68 (m, 4H), 7.81 (d, J¼6.6 Hz, 2H), 7.43–7.40
(m, 2H), 4.36 (s, 2H), 8.75 (s, 2H), 3.12 (s, 2H), 1.98–1.90 (m, 2H), 0.90
(d, J¼6.3 Hz, 6H), 0.86 (d, J¼6.9 Hz, 6H). 13C NMR (100 MHz, CDCl3):